Although Wang and colleagues take their primary aim at the abuse of subgroup analyses in randomized clinical trials, they make clear that the abuse is equally present in observational studies: “In other settings, including observational studies, we encourage complete and thorough reporting of the subgroup analyses in the spirit of the guidelines listed. [read post]